Will Channell has over 20 years of experience in corporate finance and strategy and over 15 years of experience working in the life sciences industry. As Senior Vice President of Finance, Will is responsible for all aspects of Landmark Bio’s financial operations and planning. Prior to joining Landmark Bio, Will was Chief Financial Officer of RADD Pharmaceuticals, a seed-stage, preclinical oncology company, where he was responsible for Finance, Legal, HR, and IT services.
Will has built global finance teams and infrastructure to support multiple product launches and assisted in capital raising for a number of life sciences companies including argenx, Orchard Therapeutics and Alexion Pharmaceuticals. Will also held corporate finance and strategy roles of increasing responsibility at Covidien (now Medtronic) and Cardinal Health.
Will holds a BS in Biology from Pennsylvania State University and an MBA in Finance from Boston College.